Lymphocyte migration into the central nervous system - Implication of ICAM-1 signalling at the blood-brain barrier

Author： Greenwood J.   Etienne-Manneville S.   Adamson P.   Couraud P.-O.  

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.38, Iss.6, 2002-06, pp. : 315-322

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Blood-brain Barrier Drug Discovery for Central Nervous System Infections

By  

Current Drug Targets - Infectious Disorders, Vol. 5, Iss. 1, 2005-03 ,pp. : 65-72

Bentham Science Publishers

Access to resources Recommend Favorite

Solving the Blood-Brain Barrier Challenge for the Effective Treatment of HIV Replication in the Central Nervous System

By  

Current Pharmaceutical Design, Vol. 22, Iss. 35, 2016-11 ,pp. : 5477-5486

Bentham Science Publishers

Access to resources Recommend Favorite

Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 9, 2016-11 ,pp. : 1092-1117

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of VE-cadherin in Blood-brain Barrier Integrity Under Central Nervous System Pathological Conditions

By  

Current Neuropharmacology, Vol. 16, Iss. 9, 2018-11 ,pp. : 1375-1384

Bentham Science Publishers

Access to resources Recommend Favorite

Metabolic Signaling to the Central Nervous System: Routes Across the Blood Brain Barrier

By  

Current Pharmaceutical Design, Vol. 20, Iss. 9, 2014-03 ,pp. : 1392-1399

Bentham Science Publishers

Access to resources Recommend Favorite